April 18, 2018 / 11:18 AM / 5 months ago

BRIEF-CSPC Pharmaceutical Announces A Product Licensing Agreement

April 18 (Reuters) - CSPC Pharmaceutical Group Ltd :

* UNIT ENTERED PRODUCT LICENSING AGREEMENT WITH GALAXY BIO, INC. FOR LICENSING & COMMERCIALIZATION OF “PACLITAXEL FOR INJECTION”

* GALAXY BIO TO PAY PRESCRIBED PCT OF NET PROFIT OF PRODUCT IN TERRITORY TO UNIT AS SALES ROYALTY DURING 20 YEAR TERM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below